Story thread · 2 reports / 2 sources
Fidelity-Backed RNAi Drugmaker City Therapeutics Files for IPO
bloomberg.com · 15h · first report
City Therapeutics Inc. filed for an initial public offering as it looks to secure more funding for drugs that treat disease by silencing disease-related proteins.
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.